SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?


To: Alastair McIntosh who wrote (78484)10/17/2004 11:48:14 PM
From: LindyBill  Read Replies (1) | Respond to of 793804
 
None of this has anything to do with government purchasing. I can't find anything on the web confirming central purchasing of flu vaccine except to stockpile a tiny 4.5 million doses (about 5%) of demand.

With Few Suppliers of Flu Shots, Shortage Was Long in Making
By DENISE GRADY
NEW YORK TIMES
Published: October 17, 2004

.....In recent decades, many drug companies in the United States abandoned the manufacture of vaccines, saying that they were expensive to make, underpriced and not profitable enough. Flu vaccine can be a particular gamble, because the demand for it varies from year to year and companies throw away what they do not sell because a new vaccine must be made each year to deal with changing strains of the virus. Some companies dropped out because of lawsuits, and others because they determined that it would not pay to retool aging vaccine plants to meet regulatory standards......

nytimes.com

THE FLU SHOT QUESTION
By Michelle Malkin · October 14, 2004 06:15 AM
......shortage of the flu vaccine may lead to more deaths than the terrorist attacks that occurred on September 11, 2001. What makes me angry is that this didn't have to happen. The technology exists to manufacture an abundant supply of vaccines at a reasonable cost. But it sometimes doesn't work that way because penny-pinching public officials have set up a government-run vaccine purchasing system that pays ridiculously low prices. As a result, scores of companies have stopped making vaccines.......the main underlying problem--the low-price bulk purchase of vaccines by the CDC--that has driven so many vaccine makers from the industry.

michellemalkin.com



To: Alastair McIntosh who wrote (78484)10/18/2004 8:01:09 AM
From: John Carragher  Read Replies (2) | Respond to of 793804
 
Chiron,vaccine manufacturers were having quality control problems , Chiron knowing they were having problems with contamination were going ahead to distribute vaccine until they were shut down.

I assume Chiron value system must be at a all time low. From everything i read they would have released the vaccine to all u.s. citizens unless they were stopped by English gov. and later confirmed by fda.

It is really scary to think Chiron knowing they had problems would still have gone ahead and released this medication. It makes me wonder how reliable and safe are any Chiron products? What is this companies value system. I would think the board of directors have some serious investigations to do internally with management as to quality control and decision making.